These patients, while nutritionally compromised per GNRI, exhibited lower inflammatory markers (CRP, ferritin), less severe vascular calcification, and better survival outcomes compared to the sarcopenia and MSS groups. The gene discussed is CRP; the disease is Marinesco-Sjogren syndrome.